| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.21B | 8.65B | 8.42B | 8.34B | 6.99B | 6.10B |
| Gross Profit | 4.72B | 4.47B | 4.40B | 4.15B | 3.56B | 3.18B |
| EBITDA | 2.22B | 2.11B | 2.04B | 1.88B | 1.66B | 1.39B |
| Net Income | 1.22B | 1.17B | 1.15B | 999.50M | 904.50M | 681.20M |
Balance Sheet | ||||||
| Total Assets | 16.56B | 16.07B | 14.84B | 14.42B | 14.03B | 12.91B |
| Cash, Cash Equivalents and Short-Term Investments | 2.69B | 2.08B | 2.82B | 2.40B | 2.79B | 2.79B |
| Total Debt | 5.99B | 5.09B | 4.82B | 4.67B | 5.31B | 5.39B |
| Total Liabilities | 9.56B | 8.53B | 8.11B | 7.77B | 8.31B | 8.00B |
| Stockholders Equity | 6.98B | 7.53B | 6.72B | 6.64B | 5.72B | 4.90B |
Cash Flow | ||||||
| Free Cash Flow | 1.32B | 1.28B | 1.58B | 1.03B | 942.20M | 1.13B |
| Operating Cash Flow | 1.55B | 1.52B | 1.84B | 1.24B | 1.11B | 1.16B |
| Investing Cash Flow | -679.70M | -1.74B | -413.30M | -463.50M | -466.90M | -850.40M |
| Financing Cash Flow | -261.70M | -535.80M | -927.00M | -1.23B | -687.10M | 823.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €10.45B | 10.47 | 14.39% | 4.34% | 7.71% | -2.82% | |
73 Outperform | €5.26B | 11.00 | 25.83% | 2.15% | 12.65% | 81.77% | |
67 Neutral | €8.66B | 34.91 | 4.63% | 4.04% | 2.16% | -64.02% | |
66 Neutral | €7.33B | 36.10 | 10.66% | 2.48% | 10.87% | -10.35% | |
65 Neutral | €40.34B | 14.40 | 11.84% | 2.72% | 1.09% | -0.94% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | €38.61B | 31.80 | 17.67% | 1.70% | 10.57% | 13.41% |